December 26, 2017 Comments Off on New patent expiration for Kastle Theraps drug KYNAMRO Posted in: Uncategorized
Annual Drug Patent Expirations for KYNAMRO Kynamro is a drug marketed by Kastle Theraps Llc and is included in one NDA. There are three patents protecting this drug. This drug…
The post New patent expiration for Kastle Theraps drug KYNAMRO appeared fir…
December 26, 2017 Comments Off on New patent expiration for Novo Nordisk drug NORDITROPIN FLEXPRO Posted in: Uncategorized
Annual Drug Patent Expirations for NORDITROPIN+FLEXPRO Norditropin Flexpro is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from two suppliers. There are…
The post New patent expiration for Novo Nordisk drug NORD…